Glaxo Smith Kline 58160072552 - Fluarix® Trivalent 2026 - 2027 Influenza Virus Vaccine, Trivalent Inactivated, Preservative Free 45 mcg / 0.5 mL Injection 0.5 mL - 1/Box
- FLUARIX (Influenza Vaccine)
- Injectable Suspension, for Intramuscular Use
- 2026-2027 Formula
This product can be found in our Clinical -> Pharmaceuticals -> Vaccines -> Influenza section.
- SKU
- 100-1286098BX
Description / Glaxo Smith Kline 58160072552 - Fluarix® Trivalent 2026 - 2027 Influenza Virus Vaccine, Trivalent Inactivated, Preservative Free 45 mcg / 0.5 mL Injection 0.5 mL - 1/Box
Fluarix Trivalent 2026 - 2027 is an influenza virus vaccine, a trivalent inactivated vaccine that is preservative free. It is a flu vaccine supplied as a 0.5 mL injection in a prefilled syringe. It is indicated for people 6 months of age and older.
- Trivalent inactivated influenza virus vaccine, 2026 - 2027 season
- Preservative free
- Injection, 45 mcg / 0.5 mL
- Intramuscular type
- Prefilled syringe container
- 0.5 mL volume
- Indicated for people 6 months of age and older
- Made by Glaxo Smith Kline, manufacturer number 58160072552
More Information
| Unit Of Measure | Box |
|---|---|
| Product Dating | McKesson Acceptable Dating: we will ship >= 30 days |
| NDC Buy | 58160072552 |
| Generic Drug Name | Influenza Virus Vaccine, Trivalent Inactivated, Preservative Free |
| Buy American Act (BAA) Compliant | No |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 51201608 |
| Product Notice |
License Required Global Location Number (GLN) Required |
| Manufacturer Name | Glaxo Smith Kline |
| Manufacturer Number | 58160072552 |
| Application | Flu Vaccine |
| Brand Or Series | Fluarix® Trivalent 2026 - 2027 |
| Qty Per Unit of Measure | 1 |
| Container Type | Prefilled Syringe |
| Dosage Form | Injection |
| Volume | 0.5 mL |
| Strength | 45 mcg / 0.5 mL |
| Type | Intramuscular |
| User | Indicated for People 6 Months of Age and Older |